Parkinson's disease (PD) * involves degeneration of dopaminergic neurons of the substantia nigra (SN) . Oxidative stress appears to play a major role in the death of these neurons. Dopaminergic neurons are believed to be especially prone to oxidative stress due to the potential for dopamine oxidation to occur either through auto-oxidation or via metabolism by the enzyme monoamine oxidase (MAO). Oxidation of dopamine produces reactive oxygen species (ROS) including hydrogen peroxide (H2O2). H2O2 can react with ferrous (Fe 2+ ) iron to produce hydroxyl radicals (OH . ) which can damage nearby proteins, nucleic acids and membrane phospholipids 1 . Iron levels are increased in the SN of PD patients along with elevations in various indices of oxidative damage 2-4 .
PD is also characterized by decreases in SN levels of the thiol antioxidant glutathione (GSH).
Although GSH is not the only antioxidant molecule reported to be altered in PD, the magnitude of GSH depletion appears to parallel disease severity and it is the earliest known indicator of oxidative stress in presymptomatic PD, preceding decreases in both mitochondrial complex I activity and dopamine levels 5, 6 . Nigral neurons contain GSH and levels are reduced in the PD brain 7 .
GSH is synthesized by a two-step reaction involving the enzymes γ-GCS and glutathione synthetase. γ-GCS is the rate-limiting enzyme in this process and brain GSH appears to primarily arise through synthesis from its constituent amino acids via this enzyme 8 . γ-GCS is a ________________________ * Abbreviations: PD, Parkinson's disease; SN, substantia nigra; GSH, Glutathione; γ -GCS, gamma glutamyl cysteine synthetase; dox, doxycycline. dimer composed of a heavy catalytic subunit and a light regulatory subunit 9 .
GSH is synthesized in the cytosol and transported into the mitochondria via an energydependent transporter 8 . The mitochondria contains GSH peroxidase and all other components necessary for detoxification of hydroperoxides but no catalase. Decreases in GSH availability in the brain therefore is believed to promote mitochondrial damage via increased ROS 10 .
Mitochondrial dysfunction appears to play a role in the neurodegeneration associated with PD 1 .
We have created permanent PC12 cell lines in which GSH can be inducibly down-regulated by expressing antisense rat γ-GCS heavy and light subunit cDNAs in a reverse doxycycline (dox)-inducible system making decreases in GSH levels drug-dependent. These cells were used to explore the affects of lowering GSH levels on mitochondrial function in dopaminergic cells as a model for PD.
EXPERIMENTAL PROCEDURES
Materials. Tissue culture supplies were obtained from Gibco. All other chemicals were obtained from Sigma unless otherwise stated.
Creation of dox-inducible anti γ-GCS PC12 cell lines. Dox inducible anti γ-GCS lines (anti γ-GCS) were produced by transfecting PC12 cells with pUHD172-1neo regulatory plasmid using lipofectamine reagent ® (Gibco) (Fig. 1 ). Cells were grown for 15 days in media containing 1mg/ml geneticin (G418). Resulting drug-resistant colonies were transiently transfected with response plasmid containing lacZ (pBIG, Clontech) and treated with either 0 or 25 ug/ml dox followed by X-Gal staining to identify rTta lines with low basal expression and high dox inducibility (data not shown). These lines were stably transfected with response plasmid (pBI, Clontech) containing antisense heavy and light rat γ-GCS cDNAs cloned via RT-PCR from adult rat brain tissue using primers generated from previously published sequences 9,11 . Cells were grown in media containing 1mg/ml G418 and 200ug/ml hygromycin for 15 days and drugresistant colonies selected. Experiments were run on two to three separate anti γ-GCS cell lines using cells containing rTta alone as a negative control.
Measurement of γ-GCS heavy and light subunit protein levels by Western blot analysis. Western blot analysis of cell extracts from anti γ-GCS and rTta cells grown in the presence of increasing concentrations of dox was performed as previously described 12 .
Gamma glutamyl cysteine synthetase activity. Cell homogenates resuspended in 100 mM TrisCl, pH 8.0 were used to assay γ-GCS activity levels as previously described 11 . Assays were run in the absence of alpha-aminobutyrate as blank. γ-GCS values were normalized per protein using reagent from BioRad.
Glutathione (GSH) and glutathione disulfide (GSSG) levels in whole cells and mitochondria.
Cellular GSH and GSSG levels were measured by the method of Griffith (1980) . Total GSH and GSSG was measured after addition of 5'-5' dithiobis(2-nitrobenzoic acid), 3 carboxy-4 nitrophenyl disulfide (DTNB) at an absorbance of 412 nm 13 . GSSG was selectively measured after assaying samples in which GSH is masked by pretreatment with 2-vinylpyridine. The difference between the two values gives the GSH levels in the cells. For measurement of mitochondrial GSH and GSSG levels, high quality mitochondria were isolated from anti γ-GCS and control cells as previously described 14 . All values were normalized per protein and/or citrate synthetase activity. Statistical analysis. Biochemical data are given as mean +/-standard deviation and significance testing was performed using ANOVA.
RESULTS

Generation of PC12 cells with inducibly reduced GSH levels. Using a reverse doxycycline
inducible system, we have generated PC12 cell lines in which activity levels of γ-GCS, the ratelimiting enzyme in GSH synthesis, can be inducibly down-regulated via addition of dox ( Fig.1 ).
Western blot analysis of anti γ-GCS cells demonstrated that increasing concentrations of dox
resulted in a dose-dependent decrease in levels of both heavy and light subunit γ-GCS protein in these cells ( Fig. 2A and B) . No corresponding decrease in either heavy or light γ-GCS subunit protein was seen in rTta control cells treated with dox at the same concentrations (data not shown). Levels of γ-GCS activity were also found to decrease in antisense γ-GCS containing cell lines in a dose-dependent manner following treatment with dox (Fig. 3A) . In contrast, control rTta cells showed no significant changes in γ-GCS activity. Dox-dependent decreases in γ-GCS levels were found to vary proportionally with time up to at least 72 hours following initial drug induction while no change was observed in γ-GCS enzyme levels in the rTta control cells (Fig 3B) . Cells containing only rTta plasmid showed no significant changes in γ-GCS levels for cultures incubated for the same time periods.
The dependence of the levels of total cellular glutathione (GSH and its oxidized form, GSSG) on dox concentration were seen to parallel γ-GCS activities, decreasing with decreasing enzyme activity (Fig.3C) . Treatment with 25 ug/ml dox for 24 hours caused a decrease in GSH levels of approximately 50% in the antisense γ-GCS cell lines, a similar decrease to that observed in the SN of early PD brains 2,5,21-23 . This dosage was used for all subsequent studies unless otherwise noted.
Acute decreases in GSH levels had no effect on cell viability or growth as measured by trypan blue staining (data not shown); only rare blue cells were noted in either the rTta or antisense γ-GCS cells following a 24 hr treatment with 25 µg/ml dox.
Reduced GSH levels results in increased oxidative stress. As GSH is an important redox regulator, cellular levels of ROS and related species were estimated to examine the effects of reduced GSH levels on production of oxidative stress (Fig. 4) . Lowering GSH levels was found to cause a significant increase in both cellular and mitochondrial ROS values in the anti γ-GCS cell lines. rTta lines showed no change (data not shown).
Reduced GSH levels results in decreases in mitochondrial function due to specific inhibition of complex I via thiol oxidation. GSH is known to be synthesized in the cytoplasm and to enter the mitochondria via an energy-dependent transport-mediated process 8 . Decreases in cellular GSH in the anti γ-GCS cells following dox induction resulted in a significant decrease in both mitochondrial GSH and GSSG levels (Fig. 3D ).
The effect of decreased mitochondrial GSH levels on mitochondrial performance was quantified by measurement of cellular ATP levels (Fig.5A) as well as mitochondrial pyruvatedependent MTT reduction (Fig. 5B ) and oxygen consumption (Fig. 5C and D) . All were found to be significantly reduced after treatment with dox. These results suggest that decreasing GSH levels has a profound affect on mitochondrial function. PD appears to involve selective decreases in mitochondrial complex I activity 1,6,24,25 . MTT reduction and state 3 respiration assayed using the complex I substrate pyruvate were both found to be decreased upon GSH depletion of PC12. To see whether the effects of GSH depletion were specific to complex I or more general, we compared the activies of complex I vs. complexes II-III and IV in isolated mitochondria from dox-treated vs. untreated cells. Lowering of GSH levels in these cells resulted in a significant decrease in complex I activity but interestingly no significant losses were seen in either complex II-III or IV (Fig. 6) . Addition of the thiol reducing agent dithiothreitol (DTT) was found to restore complex I activity to levels comparable with those found in corresponding controls, indicating that the inhibition of enzyme activity is likely due to oxidation of sulfhydryl groups within the enzyme complex. DTT had no affect on either complex I activity alone, or on II-III and IV activities with or without dox addition.
Levels of reduced protein sulfhydryl residues were decreased in a dox-dependent manner in mitochondria isolated from GSH-depleted cells suggesting that decreases in cellular GSH levels results in increased thiol oxidation of mitochondrial proteins (Fig. 7A) .
Non-denaturing immunoprecipitation performed using antibodies against NADH dehydrogenase (ND1 subunit), the active enzymatic component of complex I, followed by subsequent measurement of reduced protein sulfhydryls in the immunoprecipitated fractions revealed a significant decrease in their levels in this protein following GSH depletion (Fig. 7C ). This decrease in reduced thiol groups was in the absence of any GSH depletion-mediated loss in immunoprecipitated protein levels (Fig. 7B) .
DISCUSSION
Early depletions in nigral GSH levels observed in the Parkinsonian brain are not explainable by increased oxidation of GSH to GSSG. GSH losses have been suggested to be due to increased activity of the enzyme γ-glutamyltranspeptidase resulting in increased removal of both GSH and GSSG from cells although this has yet to be definitely proven 26 . To explore the effects of a depletion in GSH on dopaminergic cells like those in the SN, we constructed a model in which levels of the rate-limiting enzyme in glutathione synthesis, γGCS, is inducibly depleted.
Although GCS activity levels do not appear to be specifically impaired in sporadic cases of PD 26 , the net effect of our genetic manipulation mimics that which is seen in the Parkinsonian brain, i.e. a decrease in GSH levels without correponding increases in GSSG levels. Using this model we have demonstrated that lowering GSH levels in PC12 appears to elicit a selective inhibition of mitochondrial complex I activity leading to decreased mitochondrial function. Decreased Our studies suggest that complex I activity is especially susceptible to decreases in GSH levels.
Previous studies have shown that complex I activity in bovine heart submitochondrial particles is particularly effected by oxidative stress and that ROS generated by the hypoxanthine-xanthine system selectively affects utilization of oxygen by NAD-linked substrates in rat brain mitochondria 25, 33 . Complex I is in fact considered to be one of the most severely affected by age-related increases in oxidative stress 34 . In synaptic mitochondria, complex I exerts a major control over oxidative phosphorylation such that at 25% inhibition, energy metabolism is GSH is known to protect proteins from oxidation by conjugating with oxidized thiol groups to form protein-SS-GSH mixed disulfides which can then be re-reduced to protein and GSH by glutathione reductase, thioredoxin, or protein disulfide isomerase 36,37 . GSH is the major cellular component involved in maintaining protein sulfhydryl groups in their reduced state and much emphasis has been placed lately on its role in redox regulation as a mechanism for controlling activities of various thiol-dependent enzymes including those involved in metabolic regulation Complex II-III (100% value, 130.0 +/-3.0 nmol/min/mg protein) and Complex IV (100% value, 500 nmol/min/mg protein) activities in anti γ-GCS cells after treatment with 0 vs. 25 ug/ml dox for 24 hours. All mitochondrial enzyme activities were measured at 25 ug/ml dox in the absence and presence of 4 mM DTT. * p < 0.01 vs. control at 0 ug/ml. DTT has no effect on complex activities at 0 ug/ml dox (data not shown).
FIG. 7. Measurement of reduced sulfhydryl groups before and after ND1 immunoprecipitation.
(A) Levels of reduced sulfhydryl residues in mitochondria isolated from anti γ-GCS cells after treatment with 0, 25, and 50 ug/ml dox for 24 hours (100% value, 90 nmol SH/mg protein).
(B)Western analysis of NADH dehydrogenase immunoprecipitates isolated from mitochondria of anti γ-GCS cells after growth in 0 vs. 25 µg/ml dox for 24 hrs; band is the 33 kD ND1 subunit.
(C) Levels of reduced sulfhydryl residues in immunoprecipitates isolated from mitochondria of anti γ-GCS cells after growth in 0 vs. 25 ug/ml dox for 24 hours.* p < 0.01 vs. control at 0 ug/ml. 21 GSH decrease leads to selective complex I inhibition by on August 30, 2007 www.jbc.org Downloaded from
